Investors in US exchange-traded funds favored Indian stocks more than any other country’s last week as China’s sluggish recovery leaves the South Asian nation as the main growth engine of emerging markets.
(Bloomberg) — Investors in US exchange-traded funds favored Indian stocks more than any other country’s last week as China’s sluggish recovery leaves the South Asian nation as the main growth engine of emerging markets.
Inflows into funds that invest in Mumbai-listed shares totaled about $638 million in the five days to July 14, while those buying Chinese equities received $223 million. The benchmark Sensex rose to a record high on Monday, extending its gains from late March to 16% in both rupee and dollar terms.
China’s Growth Disappoints as Beijing Hints at Muted Stimulus
Concerns about China deepened after the world’s second-biggest economy reported quarterly growth below estimates. With Beijing underscoring its resolve to provide only targeted support, and avoid a broader stimulus, the nation’s equity outlook remains clouded. Meanwhile, domestic consumer demand and a pause in interest-rate hikes are seen driving a 7% growth for India this year, about 1.5 percentage points faster than China’s and the quickest among major economies.
Overseas Investors Buy Net INR32.8B of India Equities on July 14
Flows trends in US ETFs last week:
- Stock ETFs expanded by $1.43 billion.
- Bond funds rose by $43.3 million.
- Total assets rose to $259.5 billion from $248.1 billion.
- The MSCI Emerging Markets Index closed up 4.9 percent from the previous week at 1,028.49 points.
- India had the biggest inflow, of $637.5 million, led by iShares MSCI India.
- Romania had the biggest outflow, of $956,870, following withdrawals from iShares Frontier and Select EM.
Click here for Bloomberg’s ETF screening applications.
Click here for BI’s Weekly Emerging Markets Fixed-Income Strategy Chart Pack
Regional Summary
Click here for Bloomberg’s ETF Excel library.
Americas
Asia Pacific
Europe, Middle East & Africa
More stories like this are available on bloomberg.com
©2023 Bloomberg L.P.